Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients

Journal of the National Cancer Institute - Tập 98 Số 3 - Trang 172-180 - 2006
Craig C. Earle1,2,3,4,5,6,7, Deborah Schrag1,2,3,4,5,6,7, Bridget A. Neville1,2,3,4,5,6,7, K. Robin Yabroff1,2,3,4,5,6,7, Marie Topor1,2,3,4,5,6,7, Angela Fahey1,2,3,4,5,6,7, Edward L. Trimble1,2,3,4,5,6,7, Diane C. Bodurka1,2,3,4,5,6,7, Robert E. Bristow1,2,3,4,5,6,7, Michael E. Carney1,2,3,4,5,6,7, Joan L. Warren1,2,3,4,5,6,7
1Affiliations of authors: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (CCE, BAN)
2Applied Research Program (KRY, JLW), Cancer Therapy Evaluation Program (ELT), National Cancer Institute, Bethesda, MD
3Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY (DS)
4Department of Gynecologic Oncology, M.D. Anderson Cancer Center, Houston, TX (DCB)
5Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD (REB)
6Department of Obstetrics, Gynecology, and Women's Health, Kapiolani Medical Center for Women and Children, Honolulu, HI (MC)
7Information Management Services, Inc., Rockville, MD (MT, AF)

Tóm tắt

Từ khóa


Tài liệu tham khảo

Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004 . CA Cancer J Clin2004 ; 54 : 8 –29.

Munoz KA, Harlan LC, Trimble EL. Patterns of care for women with ovarian cancer in the United States. J Clin Oncol1997 ; 15 : 3408 –15.

McGowan L. Patterns of care in carcinoma of the ovary. Cancer1993 ; 71 : 628 –33.

McGowan L, Lesher LP, Norris HJ, Barnett M. Misstaging of ovarian cancer. Obstet Gynecol1985 ; 65 : 568 –72.

Nguyen HN, Averette HE, Hoskins W, Penalver M, Sevin BU, Steren A. National survey of ovarian carcinoma. Part V. The impact of physician's specialty on patients' survival. Cancer1993 ; 72 : 3663 –70.

Eisenkop SM, Spirtos NM, Montag TW, Nalick RH, Wang HJ. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol1992 ; 47 : 203 –9.

NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA1995 ; 273 : 491 –7.

Young RC, Decker DG, Wharton JT, Piver MS, Sindelar WF, Edwards BK, et al. Staging laparotomy in early ovarian cancer. JAMA1983 ; 250 : 3072 –6.

Wu PC, Qu JY, Lang JH, Huang RL, Tang MY, Lian LJ. Lymph node metastasis of ovarian cancer: a preliminary survey of 74 cases of lymphadenectomy. Am J Obstet Gynecol1986 ; 155 : 1103 –8.

Sonoda Y. Management of early ovarian cancer. Oncology2004 ; 18 : 343 –56.

Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER program of the National Cancer Institute. Cancer1995 ; 76 : 2343 –50.

Nattinger AB, McAuliffe TL, Schapira MM. Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol1997 ; 50 : 939 –45.

Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK, editors. SEER Cancer Statistics Review, 1973–1994. NIH publication 97–2789. Bethesda (MD): National Cancer Institute; 1997 . Available at: http://seer.cancer.gov/csr/1973_1994/ . [Last accessed: December 23, 2005.]

Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care1993 ; 31 : 732 –48.

Klabunde CN. Development of a comorbidity index using physician claims data. J Clin Epidemiol2000 ; 53 : 1258 –67.

Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol1992 ; 45 : 613 –9.

Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis1987 ; 40 : 373 –83.

Harlan LC, Clegg LX, Trimble EL. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol2003 ; 21 : 3488 –94.

Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care2002 ; 40 : 55 –61.

Earle CC, Tsai JS, Gelber RD, Weinstein MC, Neumann PJ, Weeks JC. Effectiveness of palliative chemotherapy for advanced lung cancer: instrumental variable and propensity analysis. J Clin Oncol2001 ; 19 : 1064 –70.

Schrag D, Earle C, Xu F, Panageas KS, Yabroff KR, Bristow RE, et al. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst2006 ; 98 : 163 –71.

Trimbos JB, Schueler JA, van Lent M, Hermans J, Fleuren GJ. Reasons for incomplete surgical staging in early ovarian carcinoma. Gynecol Oncol1990 ; 37 : 374 –7.

Twickler DM, Forte TB, Santos-Ramos R, McIntire D, Harris P, Scott D. The Ovarian Tumor Index predicts risk for malignancy. Cancer1999 ; 86 : 2280 –90.

Junor EJ, Hole DJ, McNulty L, Mason M, Young J. Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol1999 ; 106 : 1130 –6.

Thông tin
Thông tin xuất bản

Journal of the National Cancer Institute

Tập 98 Số 3

172-180

Thông tin tác giả